Wegovy Flextouch 2.4mg (German)

WEGOVY® FLEXTOUCH® 2.4mg (German) is a dose-escalation stage in the Wegovy (semaglutide) treatment plan for chronic weight management in adults with obesity or overweight-related health risks. It is the second step in the four-dose escalation process designed to improve tolerability of the medication and optimize weight loss outcomes.

Semaglutide works by mimicking the GLP-1 hormone, which helps regulate appetite and food intake. This once-weekly subcutaneous injection promotes satiety, reduces caloric intake, and contributes to clinically significant weight loss when combined with a reduced-calorie diet and increased physical activity.